Login to Your Account



NPS, Enzon Plan To Merge In Deal Valuing Combined Firm At $1.6B

By Aaron Lorenzo


Friday, February 21, 2003
NPS Pharmaceuticals Inc. and Enzon Pharmaceuticals Inc. shook hands on a merger that would create a combined company valued at $1.6 billion, a deal in which NPS essentially is offering about $750 million in stock for Enzon. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription